Home » AXM PHARMA ANNOUNCES ADDITIONAL FINANCING AND FINAL SFDA INSPECTION OF FACTORY RESCHEDULED
AXM PHARMA ANNOUNCES ADDITIONAL FINANCING AND FINAL SFDA INSPECTION OF FACTORY RESCHEDULED
AXM Pharma has announced that the company's Series B Preferred Shareholders have exercised warrants resulting in net proceeds of US$1,200,000. The warrants were converted at a price of $3.00. In addition, AXM announced that final inspection of their new factory has been rescheduled by the State Food and Drug Administration (SFDA) for the week of Jan. 10, 2005.
Yahoo News (http://biz.yahoo.com/iw/050106/078550.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct